Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;18(1):29-37.
doi: 10.1038/s41589-021-00889-1. Epub 2021 Oct 28.

Increasing the efficiency and precision of prime editing with guide RNA pairs

Yuan Zhuang #  1 , Jiangle Liu #  1   2   3 , Hao Wu #  1   2   3 , Qingguo Zhu  1 , Yongchang Yan  1   2   3 , Haowei Meng  1 , Peng R Chen  2   3   4 , Chengqi Yi  5   6   7
Affiliations

Increasing the efficiency and precision of prime editing with guide RNA pairs

Yuan Zhuang et al. Nat Chem Biol. 2022 Jan.

Abstract

The recently reported prime editor (PE) can produce all types of base substitution, insertion and deletion, greatly expanding the scope of genome editing. However, improving the editing efficiency and precision of PE represents a major challenge. Here, we report an approach termed the homologous 3' extension mediated prime editor (HOPE). HOPE uses paired prime editing guide RNAs (pegRNAs) encoding the same edits in both sense and antisense DNA strands to achieve high editing efficiency in human embryonic kidney 293T cells as well as mismatch repair-deficient human colorectal carcinoma 116 cells. In addition, we found that HOPE shows greatly improved product purity compared to the original PE3 system. We envision that this enhanced tool could broaden both fundamental research and therapeutic applications of prime editing.

PubMed Disclaimer

References

    1. Komor, A. C., Badran, A. H. & Liu, D. R. CRISPR-based technologies for the manipulation of eukaryotic genomes. Cell 169, 559 (2017). - DOI
    1. Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229–236 (2020). - DOI
    1. Lee, J. et al. Recent advances in genome editing of stem cells for drug discovery and therapeutic application. Pharmacol. Ther. 209, 107501 (2020). - DOI
    1. Wang, D., Zhang, F. & Gao, G. CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181, 136–150 (2020). - DOI
    1. Anzalone, A. V. et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576, 149–157 (2019). - DOI

Publication types